Pascale Tomasini
Researcher Next ID · RN-042867
Researcher · Biochemistry, Genetics and Molecular Biology
Centre National de la Recherche Scientifique
Paris, New Zealand
- Works count
- 326
- Citation count
- 4,751
- H-index
- 33
- i10-index
- 68
Research interests
Publications
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
Annals of Oncology · 2023 · https://doi.org/10.1016/j.annonc.2023.10.117
Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial
Journal of Clinical Oncology · 2022 · https://doi.org/10.1200/jco.22.00393
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR -mutated non-small cell lung cancer (NSCLC)
Lung Cancer · 2017 · https://doi.org/10.1016/j.lungcan.2017.06.014
Current projects
No projects listed.